Shouyao Holdings (Beijing) Co., LTD.

SHSE:688197 Stock Report

Market Cap: CN¥4.3b

Shouyao Holdings (Beijing) Past Earnings Performance

Past criteria checks 0/6

Shouyao Holdings (Beijing)'s earnings have been declining at an average annual rate of -1.2%, while the Pharmaceuticals industry saw earnings growing at 9.1% annually. Revenues have been declining at an average rate of 23.7% per year.

Key information

-1.2%

Earnings growth rate

8.2%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate-23.7%
Return on equity-24.3%
Net Margin-5,199.6%
Next Earnings Update28 Apr 2025

Recent past performance updates

Recent updates

We're Not Worried About Shouyao Holdings (Beijing)'s (SHSE:688197) Cash Burn

Aug 15
We're Not Worried About Shouyao Holdings (Beijing)'s (SHSE:688197) Cash Burn

Here's Why We're Not At All Concerned With Shouyao Holdings (Beijing)'s (SHSE:688197) Cash Burn Situation

Apr 29
Here's Why We're Not At All Concerned With Shouyao Holdings (Beijing)'s (SHSE:688197) Cash Burn Situation

Revenue & Expenses Breakdown

How Shouyao Holdings (Beijing) makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:688197 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244-20922220
31 Mar 245-19222207
31 Dec 235-18621202
30 Sep 235-19121207
30 Jun 235-18321206
31 Mar 232-17021202
31 Dec 222-17421199
30 Sep 224-16019188
30 Jun 228-15918186
31 Mar 229-16119170
31 Dec 2113-14520157
30 Sep 2111-13423134
31 Mar 214-349263118
31 Dec 207-33025685
31 Dec 1912-40844
31 Dec 1820-121032
31 Dec 1731-4927

Quality Earnings: 688197 is currently unprofitable.

Growing Profit Margin: 688197 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688197 is unprofitable, and losses have increased over the past 5 years at a rate of 1.2% per year.

Accelerating Growth: Unable to compare 688197's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 688197 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-1.2%).


Return on Equity

High ROE: 688197 has a negative Return on Equity (-24.33%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/15 10:34
End of Day Share Price 2025/01/15 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shouyao Holdings (Beijing) Co., LTD. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shitong HanCitic Securities Co., Ltd.